|
 The conference of the American Academy of Anti-Aging Medicine will, as usual, range far and wide in its annual presentation of anti-aging research.
The Dec. 13-15 conference at the Alexis Park Resort in Las Vegas, Nev., will cover the world of anti-aging medicine and research. The conference's mottos-"Welcome to the Future of Medicine," and "Join the Ageless Society"-pinpoint the purposes of A4M, and the projected scope of this intriguing three-day conference.
While the daily sessions cover the essentials of today's anti-aging efforts, some of the presentations stand out as particularly intriguing. They include how humans may beresuscitated after "death," the status of suspended animation research and body sustainment, and the latest in brain transplant technologies.
A session titled, "The next advance in human resuscitation technology," will be led by Peter Safar, M.D., of the Safar Center for Resuscitation Research at the University of Pittsburgh.
Safar is internationally recognized as the principal developer of cardiopulmonary resuscitation (CPR), and the initiator of modern day emergency medicine education in the U.S. Adding perspective from the world of commercial suspended animation efforts will be Paul Segall, Ph.D., of BioTime Inc., a Berkeley, Calif., company.
And, if there is still anyone who doubts that the concept of extending lifespan through groundbreaking technologies is increasingly in the forefront of legitimate medical research, they need only attend the presentation of Robert White, world-renowned author, scientist and brain surgeon at Case Western Reserve University School of Medicine. White will present a discussion on the latest in brain transplant technologies.
Many of the sessions will detail medical interventions and vitamin-mineral supplementation. Marguerite Kay, Ph.D., Regents Professor of Microbiology and Immunology at the University of Arizona in Phoenix, will talk on "The role of vitamin E in the prevention and treatment of immune system disorders and neurodegenerative diseases." Thomas Cook, Ph.D., and consultant to Lederle Labs, Bristol Myers Squibb and other companies, will lead a session on "Use of phosphatidylserine in the prevention, arrest and treatment of Alzheimer's disease."
Other sessions will detail new developments in the neurophysiology of Alzheimer's; therapies to improve memory and the mind; the genetic repair of aging eyesight; and hormone replacement therapy, including both human growth hormone and testosterone hormone.
Innovative Houston cancer researcher Stanislaw Burzynski will present the results of his work with antineoplastins, naturally occurring peptides and amino acid derivatives, in the treatment of malignant brain tumors.
Vernon Howard, Ph.D., and co-founder of the graduate school of education at Harvard University, will discuss ethical considerations of anti-aging medical therapies. Early registration (before October 1) is $475, but both A4M and Life Extension Foundation members pay only $395.
For more information, or to register, call 1-800-634-6133.
|